Loading...
IM Cannabis Corp.
IMCC•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$2.80
$-0.01(-0.36%)
IM Cannabis Corp. (IMCC) Financial Performance & Income Statement Overview
Review IM Cannabis Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
10.71%
↑ 10.71%
Operating Income Growth
15.94%
↑ 15.94%
Net Income Growth
-11.44%
↓ 11.44%
Operating Cash Flow Growth
86.66%
↑ 86.66%
Operating Margin
-28.84%
↓ 28.84%
Gross Margin
18.58%
↑ 18.58%
Net Profit Margin
-8.61%
↓ 8.61%
ROE
-79.48%
↓ 79.48%
ROIC
-379.37%
↓ 379.37%
IM Cannabis Corp. (IMCC) Income Statement & Financial Overview
Review IM Cannabis Corp.'s (IMCC) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $13.34M | $13.88M | $14.75M | $12.06M |
| Cost of Revenue | $10.65M | $10.73M | $13.91M | $10.28M |
| Gross Profit | $2.68M | $3.15M | $844000.00 | $1.78M |
| Gross Profit Ratio | $0.20 | $0.23 | $0.06 | $0.15 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $790000.00 | $4.10M | $3.73M | $4.66M |
| Operating Expenses | $22.37M | $2.19M | -$2.02M | $7.41M |
| Total Costs & Expenses | $33.02M | $12.93M | $17.64M | $17.69M |
| Interest Income | $0.00 | $0.00 | $0.00 | $487000.00 |
| Interest Expense | $0.00 | $0.00 | $1.43M | $501000.00 |
| Depreciation & Amortization | $542000.00 | $451000.00 | $474000.00 | $717000.00 |
| EBITDA | -$1.07M | -$502000.00 | -$2.40M | -$4.91M |
| EBITDA Ratio | -$0.08 | -$0.04 | -$0.16 | -$0.41 |
| Operating Income | -$19.69M | $953000.00 | -$2.89M | -$5.63M |
| Operating Income Ratio | -$1.48 | $0.07 | -$0.20 | -$0.47 |
| Other Income/Expenses (Net) | $18.43M | -$2.06M | -$1.41M | -$501000.00 |
| Income Before Tax | -$1.26M | -$1.11M | -$4.29M | -$6.13M |
| Income Before Tax Ratio | -$0.09 | -$0.08 | -$0.29 | -$0.51 |
| Income Tax Expense | -$47000.00 | -$26000.00 | -$839000.00 | -$111000.00 |
| Net Income | -$1.01M | -$922000.00 | -$3.03M | -$5.62M |
| Net Income Ratio | -$0.08 | -$0.07 | -$0.21 | -$0.47 |
| EPS | -$0.45 | -$0.41 | -$1.38 | -$0.42 |
| Diluted EPS | -$0.45 | -$0.41 | -$1.38 | -$0.42 |
| Weighted Avg Shares Outstanding | $3.09M | $2.23M | $2.19M | $13.39M |
| Weighted Avg Shares Outstanding (Diluted) | $3.09M | $2.23M | $2.19M | $13.39M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan